FDA Approves Abuse-Resistant Painkiller

Getty
Ray Gustini 525 Views Jun 20, 2011

Coming soon to a medicine cabinet near you: Oxecta, a short-acting painkiller that the Wall Street Journal likens to "an immediate-release version of oxycodone...designed to prevent drug tampering and misabuse."

Pfizer and Acura Pharmaceuticals Inc. both said Monday that regulators from the Food and Drug Administration approved the drug for sale. Pfizer acquired the marketing rights to the drug in March, and Acura designed the technology for the drug, which prevents it from being crushed and snorted. Bloomberg's Catherine Larkin reports that Acura expects Pzizer to Acura to "begin selling Oxecta late in the third quarter or early in the fourth quarter of this year."

News of the approval prompted Acura's shares to increase by 75 percent, the Nasdaq's biggest intraday percentage increase in 22 years, writes Larkin. Nonetheless, Cowen & Co. market analyst Ian Sanderson tells Bloomberg he's skeptical about how much the drug will help Pfizer's bottom line. “While the Acura technology does prevent them from being crushed and snorted and chewed, the primary means of abuse is still wide open," he says. "It really does not have a lot of commercial potential.

Want to add to this story? Let us know in comments or send an email to the author at rgustini at theatlantic dot com. You can share ideas for stories on the Open Wire.

Related Articles   More by Ray Gustini

Paralyzed Man Stands Thanks to Experimental Spine Implant

Earlobe Stretchers Have Regrets

Pfizer Recalls 1 Million Birth Control Pills

 

The Problem With Translated Books; The Devil Wears a Hoodie?

Kanye's Not Singing About Kim; Prince Harry Kissed His Brother's Dog

User Comments

Please type your comment and click Post. If you’re not already logged in you will be prompted to log in or register

  • The Atlantic Wire on Twitter
  • The Atlantic Wire RSS Feed
  • The Atlantic Wire iPhone App